Support by a grant from the National High Technology Research and Development Program, China (No.2002AA216041).
Objective: To construct a non-replicating vaccinia virus expressing human papillomavirus 16 (HPV16) L1, L2E7 proteins as a candidate vaccine for cervical cancer. Methods: Using vaccinia virus vector, we generated ...